123 related articles for article (PubMed ID: 38000649)
1. Enhanced intracellular accumulation and cytotoxicity of bortezomib against liver cancer cells using N-stearyl lactobionamide surface modified solid lipid nanoparticles.
Mostafaei F; Hemmati S; Valizadeh H; Mahmoudian M; Sarfraz M; Abdi M; Torabi S; Baradaran B; Vosough M; Zakeri-Milani P
Int J Pharm; 2024 Jan; 649():123635. PubMed ID: 38000649
[TBL] [Abstract][Full Text] [Related]
2. Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma.
Xu Y; Wang M; Ning S; Yang Z; Zhou L; Xia X
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296377
[TBL] [Abstract][Full Text] [Related]
3. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
[TBL] [Abstract][Full Text] [Related]
4. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
Varshosaz J; Hassanzadeh F; Sadeghi H; Khadem M
J Liposome Res; 2012 Sep; 22(3):224-36. PubMed ID: 22385296
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib-loaded solid lipid nanoparticles: preparation, characterization, and intestinal permeability investigation.
Mahmoudian M; Valizadeh H; Zakeri-Milani P
Drug Dev Ind Pharm; 2018 Oct; 44(10):1598-1605. PubMed ID: 29874944
[TBL] [Abstract][Full Text] [Related]
6.
Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
[TBL] [Abstract][Full Text] [Related]
8. Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability.
Wang W; Zhao X; Hu H; Chen D; Gu J; Deng Y; Sun J
Drug Deliv; 2010 Apr; 17(3):114-22. PubMed ID: 20148709
[TBL] [Abstract][Full Text] [Related]
9. Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.
Zuccari G; Milelli A; Pastorino F; Loi M; Petretto A; Parise A; Marchetti C; Minarini A; Cilli M; Emionite L; Di Paolo D; Brignole C; Piaggio F; Perri P; Tumiatti V; Pistoia V; Pagnan G; Ponzoni M
J Control Release; 2015 Aug; 211():44-52. PubMed ID: 26031842
[TBL] [Abstract][Full Text] [Related]
10. Apocynin-loaded PLGA nanomedicine tailored with galactosylated chitosan intrigue asialoglycoprotein receptor in hepatic carcinoma: Prospective targeted therapy.
Anter HM; Aman RM; Othman DIA; Elamin KM; Hashim IIA; Meshali MM
Int J Pharm; 2023 Jan; 631():122536. PubMed ID: 36572262
[TBL] [Abstract][Full Text] [Related]
11. Capsaicin-loaded solid lipid nanoparticles: design, biodistribution, in silico modeling and in vitro cytotoxicity evaluation.
Kunjiappan S; Sankaranarayanan M; Karan Kumar B; Pavadai P; Babkiewicz E; Maszczyk P; Glodkowska-Mrowka E; Arunachalam S; Ram Kumar Pandian S; Ravishankar V; Baskararaj S; Vellaichamy S; Arulmani L; Panneerselvam T
Nanotechnology; 2021 Feb; 32(9):095101. PubMed ID: 33113518
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
[TBL] [Abstract][Full Text] [Related]
13. Glycine-Poly-L-Lactic Acid Copolymeric Nanoparticles for the Efficient Delivery of Bortezomib.
Rajoria S; Rani S; Chaudhari D; Jain S; Gupta U
Pharm Res; 2019 Sep; 36(11):160. PubMed ID: 31520196
[TBL] [Abstract][Full Text] [Related]
14. Preparation of novel butyryl galactose ester-modified coix component microemulsions and evaluation on hepatoma-targeting in vitro and in vivo.
Liu MJ; Qu D; Chen Y; Liu CY; Liu YP; Ding XF
Drug Deliv; 2016 Nov; 23(9):3444-3451. PubMed ID: 27198659
[TBL] [Abstract][Full Text] [Related]
15. Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation.
Rahman M; Almalki WH; Afzal O; Alfawaz Altamimi AS; Kazmi I; Al-Abbasi FA; Choudhry H; Alenezi SK; Barkat MA; Beg S; Kumar V; Alhalmi A
Int J Nanomedicine; 2020; 15():9283-9299. PubMed ID: 33262588
[TBL] [Abstract][Full Text] [Related]
16. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
Cheng M; Ma D; Zhi K; Liu B; Zhu W
Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
[TBL] [Abstract][Full Text] [Related]
18. Apigenin-loaded galactose tailored PLGA nanoparticles: A possible strategy for liver targeting to treat hepatocellular carcinoma.
Ganguly S; Dewanjee S; Sen R; Chattopadhyay D; Ganguly S; Gaonkar R; Debnath MC
Colloids Surf B Biointerfaces; 2021 Aug; 204():111778. PubMed ID: 33915380
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of pectin-deoxycholic acid conjugate for targeted delivery of anticancer drugs in hepatocellular carcinoma.
Varshosaz J; Sadri F; Rostami M; Mirian M; Taymouri S
Int J Biol Macromol; 2019 Oct; 139():665-677. PubMed ID: 31377298
[TBL] [Abstract][Full Text] [Related]
20. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
[No Abstract] [Full Text] [Related]
[Next] [New Search]
